Oct 10, 2019 - Here we highlight three bigshot drug/biotech companies, which are expected to deliver positive earnings surprises in Q3.
Oct 07, 2019 - Is (AMGN) Outperforming Other Medical Stocks This Year?
Oct 03, 2019 - The FDA accepts and grants a priority review to Merck's (MRK) two filings for pediatric approvals of antibacterial medicine Dificid for Clostridium infections. The verdict will be out on Jan 24, 2020.
Oct 02, 2019 - Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Oct 02, 2019 - Top Ranked Income Stocks to Buy for October 2nd
Sep 26, 2019 - Incyte (INCY) treats first patient in the TRuE-V clinical program on the cream formulation of ruxolitinib for the treatment of vitiligo.
Sep 25, 2019 - Key highlights of the past week include regulatory and pipeline updates, licensing deals, and more.
Sep 23, 2019 - Regeneron (REGN) and Sanofi get positive CHMP recommendation for the label expansion of asthma drug Dupixent in an additional indication.
Sep 20, 2019 - Here are 5 companies with proven track records.
Sep 20, 2019 - We highlight a few key biotech stocks that surpass the sector so far in 2019 and are likely to witness a winning run in the near term.